Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | PPP2R5C |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → PPP2R5C |
| (<<) ACTN4 → PPP2R5C |
| (<<) ADCY6 → PPP2R5C |
| (<<) ATP2B4 → PPP2R5C |
| (<<) BAD → PPP2R5C |
| (<<) CASP9 → PPP2R5C |
| (<<) CSNK1D → PPP2R5C |
| (<<) GOT1 → PPP2R5C |
| (<<) HPCAL1 → PPP2R5C |
| (<<) IVL → PPP2R5C |
| (<<) KCNJ2 → PPP2R5C |
| (<<) MAP2K3 → PPP2R5C |
| (<<) MAP3K7 → PPP2R5C |
| (<<) MKNK2 → PPP2R5C |
| (<<) RAD51L3 → PPP2R5C |
| (<<) RNF11 → PPP2R5C |
| (<<) RPS6KA5 → PPP2R5C |
| Downstream (Children) |
|---|
| PPP2R5C → ANKRD27 (>>) |
| PPP2R5C → CALML5 (>>) |
| PPP2R5C → CASP6 (>>) |
| PPP2R5C → CREBBP (>>) |
| PPP2R5C → DNM1L (>>) |
| PPP2R5C → EIF2C2 (>>) |
| PPP2R5C → ENC1 (>>) |
| PPP2R5C → FA2H (>>) |
| PPP2R5C → GSTZ1 (>>) |
| PPP2R5C → GYS1 (>>) |
| PPP2R5C → ITGA3 (>>) |
| PPP2R5C → MAPK14 (>>) |
| PPP2R5C → PDGFB (>>) |
| PPP2R5C → PDK1 (>>) |
| PPP2R5C → PNO1 (>>) |
| PPP2R5C → RPL26L1 (>>) |
| PPP2R5C → RXRA (>>) |
| PPP2R5C → SAA4 (>>) |
| PPP2R5C → TGFB1 (>>) |
| PPP2R5C → TIMP2 (>>) |
